Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01728753 · ClinicalTrials.gov registry record · Phase 1
T-705a Multicenter Study in Adults Subjects With Uncomplicated Influenza
A Phase 1 study, sponsored by MDVI.
- Completed
- Registry status
- Phase 1
- Development phase
- 550
- Enrollment target
NCT01728753: Completed Phase 1 study, sponsored by MDVI.
NCT01728753 is a Phase 1 study that has completed, run by MDVI. The registered enrollment target is 550 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (817% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01728753, a Phase 1 study, has completed, sponsored by MDVI.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 550 participants
- Enrollment target
Study Summary
This is safety and pharmacokinetics (PK) of favipiravir study in adults 18-80 years of age diagnosed with uncomplicated influenza.
Interventions
- DRUG Placebo
- DRUG Favipiravir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 550 participants |
| Start Date | 2012-11 |
| Est. Completion | 2013-02 |
| Phase | Phase 1 |
What the finished NCT01728753 record still lists
NCT01728753 is an interventional study that assigns participants to a tested intervention. The registered 550 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (817% higher).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01728753 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01728753 about?
NCT01728753 is a clinical study titled "T-705a Multicenter Study in Adults Subjects With Uncomplicated Influenza". This is safety and pharmacokinetics (PK) of favipiravir study in adults 18-80 years of age diagnosed with uncomplicated influenza.
What is the current status of trial NCT01728753?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 550 participants. The study started on 2012-11. Estimated completion is 2013-02.
What interventions are being tested in trial NCT01728753?
The interventions under investigation include: Placebo (DRUG), Favipiravir (DRUG).
Who is sponsoring clinical trial NCT01728753?
This trial is sponsored by MDVI, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01728753's enrollment target sits among peer trials
550 35th of 2000 higher than 1,966 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01852448 · 550 participants
Genetics of Insulin and Incretins in Cystic Fibrosis
- NCT02995252 · 550 participants
The HOPE Study: Characterizing Patients With Hepatitis B and C
- NCT03474913 · 550 participants
Upright MRI for Prostate Cancer Screening
- NCT04761120 · 550 participants
Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia